Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 7, 2008, Pages 533-536

  Thiele, Oliver C ^a   Freier, Kolja ^a   Bacon, Claire ^a   Egerer, Gerlinde ^a   Hofele, Christof M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Chemotherapy; COSS protocol; Head and neck cancer; Maxillofacial surgery; Osteosarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GERMANY; HUMAN; MALE; MANDIBLE CANCER; MAXILLA CANCER; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; OUTCOME ASSESSMENT; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MALE; MANDIBULAR NEOPLASMS; MAXILLARY NEOPLASMS; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 50649087778     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2008.03.010     Document Type: Article

References (19)

1. Klein M.J., and Siegal G.P. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125 (2006) 555-581
2. Caron A.S., Hajdu S.I., and Strong E.W. Osteogenic sarcoma of the facial and cranial bones. A review of forty-three cases. Am J Surg 122 (1971) 719-725
3. Cotterill S.J., Wright C.M., Pearce M.S., Craft A.W., and UKCCSG/MRC Bone Tumour Working Group. Stature of young people with malignant bone tumors. Pediatr Blood Cancer 42 (2004) 59-63
4. Weber R.S., Benjamin R.S., Peters L.J., Ro J.Y., Achon O., and Goepfert H. Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 152 (1986) 386-392
5. Chidzonga M.M., and Mahomva L. Sarcomas of the oral and maxillofacial region: a review of 88 cases in Zimbabwe. Br J Oral Maxillofac Surg 45 (2007) 317-318
6. Garrington G.E., Scofield H.H., Cornyn J., and Hooker S.P. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 20 (1967) 377-391
7. Fernandes R., Nikitakis N.G., Pazoki A., and Ord R.A. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 65 (2007) 1286-1291
8. Sato M., Tanaka N., Sato T., and Amagasa T. Oral and maxillofacial tumours in children: a review. Br J Oral Maxillofac Surg 35 (1997) 92-95
9. Smeele L.E., Kostense P.J., van der Waal I., and Snow G.B. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 15 (1997) 363-367
10. Carrle D., and Bielack S.S. Current strategies of chemotherapy in osteosarcoma. Int Orthop 30 (2006) 445-451
11. Bielack S.S., Kempf-Bielack B., Delling G., et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20 (2002) 776-790
12. Salzer-Kuntschik M., Brand G., and Delling G. Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren (Determination of the degree of morphological regression following chemotherapy in malignant bone tumors). Pathologe 4 (1983) 135-141
13. Herrmann A., and Zöller J. Zur Klinik und Therapie des osteogenen Sarkoms im Kieferbereich (Clinical features and treatment of osteogenic sarcoma of the jaws). Dtsch Z Mund Kiefer Gesichtschir 14 (1990) 180-186
14. Granados-Garcia M., Luna-Ortiz K., Castillo-Oliva H.A., et al. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma. Oral Oncol 42 (2006) 172-176
15. Panizzoni G.A., Gasparini G., Clauser L., Barasti P., Pozza F., and Curioni C. Osteosarcoma of the facial bones. Ann Oncol 3 suppl 2 (1992) S47-S50
16. Doval D.C., Kumar R.V., Kannan V., et al. Osteosarcoma of the jaw bones. Br J Oral Maxillofac Surg 35 (1997) 357-362
17. Canadian Society of Otolaryngology-Head, Neck Surgery Oncology Study Group. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 33 (2004) 139-144
18. August M., Magennis P., and Dewitt D. Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg 26 (1997) 198-204
19. Jasnau S., Meyer U., Potratz J., et al., for the Cooperative Osteosarcoma Study Group COSS. Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 44 (2008) 286-294